New FDA 510(k) Clearance Highlights Ultrasound Capabilities of Longeviti ClearFit Implant

BALTIMORE, Jan. 26, 2021  — Longeviti Neuro Solutions today announced a new 510(k) clearance by the U.S Food and Drug Administration (FDA) for the ClearFit® implant that acknowledges the use of ultrasound in post-operative imaging.

More: click here